Skip to main content
. 2021 Jun 22;22(13):6679. doi: 10.3390/ijms22136679

Table 3.

Antibacterial properties of the selected compounds against clinical isolates of P. aeruginosa, K. pneumonia and MRSA strains.

Compound MIC 100 [µg/mL]
K.pneumoniae
ATCC 13883
P. aeruginosa
PA1
P. aeruginosa PA2 S. aureus
USA300
DK5 >200 100 100 >200
CAR-PEG-DK5 >200 100 100 >200
C5-DK5 50 25 25 25
C12-DK5 25 50 50 25
C12-CAR-PEG-DK5 12.5 12.5 25 12.5